Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.58 |
| ▸ | TSHR | P16473 | 6/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.58 |
| ▸ | TTR | P02766 | 3/20 | 0.58 |
| ▸ | RECQL | P46063 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 6/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5399616 | 0.86 | ERN1 (0.46) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL102065 | 0.82 | THRB (0.48) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL5310503 | 0.82 | IDO1 (0.43) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL1684148 | 0.82 | IDO1 (0.43) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL7839561 | 0.82 | PTGS1 (0.47) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL2250088 | 0.82 | IDO1 (0.43) | HSD17B10TSHRCYP3A4TTRRECQL | |
| Hydrochloric Acid SCHEMBL6267077 | 0.80 | THRB (0.46) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL22777763 | 0.80 | HSD17B10 (0.61) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL20871043 | 0.77 | MEN1 (0.46) | HSD17B10TSHRCYP3A4TTRRECQL | |
| SCHEMBL3190669 | 0.77 | IDO1 (0.40) | HSD17B10TSHRCYP3A4TTRRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| EP-1066269-B1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2005-05-11 | — | — | EP | claimed |
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | DAEYAERT FREDERIK FRANS DESIRE (BE) | 2002-08-22 | — | — | US | claimed |
| EP-1066269-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-01-10 | — | — | EP | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| WO-1999050256-A1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-10-07 | — | — | WO | claimed |
| JP-9087221-A | — | — | None | — | — | JP | disclosed |
| US-20240360124-A1 | Bromodomain Inhibitors | ABBVIE INC. (US) | 2024-10-31 | — | — | US | disclosed |
| CN-110774776-B | Method of forming electrically conductive three-dimensional articles | 施乐公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-3599077-B1 | METHOD OF FORMING CONDUCTIVE THREE-DIMENSIONAL ARTICLES | XEROX CORP (US) | 2022-02-16 | — | — | EP | disclosed |
| US-20220017511-A1 | Bromodomain Inhibitors | ABBVIE INC. (US) | 2022-01-20 | — | — | US | disclosed |
| US-20210380595-A1 | 2-(2-ACRYLOYL-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-6-(1H-INDAZOL-4-YL)-BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF G12C MUTANT KRAS PROTEIN FOR INHIBITING TUMOR METASTASIS | ARAXES PHARMA LLC (US) | 2021-12-09 | — | — | US | disclosed |
| US-5116982-A | Fluorination | DOWELANCO (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0470669-A2 | Preparation of fluorophenols, fluorohalophenols, N-acylfluoroanilines, and N-acylfluorohaloanilines | DOWELANCO (US) | 1992-02-12 | — | — | EP | disclosed |
| US-5053557-A | PROCESS FOR PREPARING 2-CHLORO-4-FLUOROPHENOL | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1991-10-01 | — | — | US | disclosed |
| EP-0417720-A2 | Process for preparing 2-chloro-4-fluorophenol | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1991-03-20 | — | — | EP | disclosed |
| US-4620042-A | Preparation of 2-chloro-4-fluorophenol from 4-fluorophenol | CENTRAL GLASS COMPANY, LIMITED (JP) | 1986-10-28 | — | — | US | disclosed |
| EP-0017209-B1 | SUBSTITUTED ALKYLAMMONIUM SALTS, THEIR PREPARATION AND USE IN PLANT GROWTH REGULATION | BASF Aktiengesellschaft (DE) | 1982-12-22 | — | — | EP | disclosed |
| US-4350518-A | Plant growth regulating substituted alkylammonium salts | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | XDH, CCR5, CXCR1 | HSD17B10 1218/4885TSHR 656/4885CYP3A4 174/4885 |
| US-20220017511-A1 | Bromodomain Inhibitors | BRD4, BRD3, BRD1 | HSD17B10 2913/4885TSHR 2279/4885CYP3A4 2255/4885 |
| US-20210380595-A1 | 2-(2-ACRYLOYL-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-6-(1H-INDAZOL-4-YL)-BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF G12C MUTANT KRAS PROTEIN FOR INHIBITING TUMOR METASTASIS | KRAS, NRAS, G3BP2 | HSD17B10 4629/4885TSHR 4148/4885CYP3A4 3748/4885 |
| US-20240360124-A1 | Bromodomain Inhibitors | BRD4, BRD3, BRD1 | HSD17B10 2913/4885TSHR 2279/4885CYP3A4 2255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.